(MedPage Today) -- The COVID-19 pandemic was linked with a global decline in the volume of stroke hospitalizations, intravenous thrombolysis (IVT), and interfacility IVT transfers, a researcher reported. From March to June 2020, stroke admissions..

Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.

Black patients with multiple sclerosis or neuromyelitis optica spectrum disorder may respond differently to a common MS therapy compared to their White peers, new research suggests.